Dementia and Geriatric Cognitive Disorders · 2001 · 23 citations · 14 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsNeurodegenerationNeurogeneticsAlzheimer DiseaseDementia GeneticsNeurodegenerative Disease GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersProtein Aggregation DisordersAlpha-synuclein AggregationAlpha-synuclein Gene VariantsAmyloid Beta PeptidesApoe GeneticsApolipoprotein E VariantsGenetic Marker AssociationNeurodegenerative GeneticsPolymorphism Studies
alpha-Synuclein has been isolated as a component of amyloid in addition to the major A beta peptide in Alzheimer disease (AD). However, there are conflicting reports regarding the association of alpha-synuclein gene polymorphism with AD. Using a novel and common polymorphism in intron 3, we examined the relationship between AD and alpha-synuclein and apolipoprotein E (ApoE) genes in 183 Japanese AD patients and 210 controls. Carriers of the alpha-synuclein deletion (D) allele had a 2.2-fold increased risk of developing AD than noncarriers in women. The odds ratio for the ApoE epsilon 4 and the alpha-synuclein D allele was 11.4 in women. The results showed that the alpha-synuclein gene is associated with sporadic AD in women, independent of ApoE epsilon 4 status.
14
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Functional Assessment Staging (FAST)
Barry Reisberg · 2001 · 1K citations